Accu-Break Pharmaceuticals
Hollywood, US · Delaware corporation
Accu-Break Pharmaceuticals develops patent-pending tablet technologies that let pharmaceutical tablets be swallowed whole or broken into precise half, third, or quarter doses using a pharmacologically inactive break region. Its technologies target drugmakers seeking dose flexibility, product life-cycle management, and extended patent protection.
Founders & leadership
RI
Robert I. GoldfarbPresident, General Counsel and Secretary
Board
EF
Elliot F. HahnExecutive Chairman and Director
NN
Nigel N. NortonBoard director
MH
Mel HarrisBoard director
RE
Robert E. BaldiniBoard director
DL
David LuckingBoard director
LA
Lloyd A. MoriberBoard director
JM
John M. SiebertBoard director
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2015
▶$500KraisedJun 2015 · 7 investors · PharmaceuticalsRule 506(b)
▶$500KraisedJun 2015 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Elliot F. HahnExecutive Officer, Director
- Robert I. GoldfarbExecutive Officer
- Nigel N. NortonDirector
- Mel HarrisDirector
- Robert E. BaldiniDirector
- David LuckingDirector
- Lloyd A. MoriberDirector
- John M. SiebertDirector
- Offering amount
- $1M
- Amount sold
- $500K
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapWalgreens5 shared keywordsWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
AARP4 shared keywordsAARP Services is the commercial arm of AARP that connects companies with the 50+ population through brand licensing, marketing, audience data, and innovation services. It helps organizations develop and market products and services tailored to aging consumers while leveraging AARP's trusted brand and member insights.
1Mg4 shared keywordsTata 1mg is India's leading online pharmacy and healthcare platform that offers medicines, lab tests, doctor consultations, and cancer care services. The company operates a digital marketplace serving Indian consumers seeking pharmaceuticals, diagnostic testing, and medical advice.
Companies competing with Accu-Break Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Accu-Break Pharmaceuticals do?
- Accu-Break Pharmaceuticals develops patent-pending tablet technologies that let pharmaceutical tablets be swallowed whole or broken into precise half, third, or quarter doses using a pharmacologically inactive break region. Its technologies target drugmakers seeking dose flexibility, product life-cycle management, and extended patent protection.
- How much funding has Accu-Break Pharmaceuticals raised?
- Accu-Break Pharmaceuticals has disclosed $500K raised across 1 round.
- Where is Accu-Break Pharmaceuticals headquartered?
- Accu-Break Pharmaceuticals is headquartered in Hollywood, US.